Advertisement
Advertisement

NVS

NVS logo

Novartis AG

150.86
USD
Sponsored
+1.71
+1.15%
May 19, 12:42 UTC -4
Open

NVS Earnings Reports

Positive Surprise Ratio

NVS beat 24 of 41 last estimates.

59%

Next Report

Date of Next Report
Jul 21, 2026
Estimate for Q2 26 (Revenue/ EPS)
$14.61B
/
$2.23
Implied change from Q1 26 (Revenue/ EPS)
+11.41%
/
+12.06%
Implied change from Q2 25 (Revenue/ EPS)
+3.95%
/
-7.85%

Novartis AG earnings per share and revenue

On Apr 28, 2026, NVS reported earnings of 1.99 USD per share (EPS) for Q1 26, missing the estimate of 2.17 USD, resulting in a -8.52% surprise. Revenue reached 13.11 billion, compared to an expected 13.92 billion, with a -5.80% difference. The market reacted with a +0.91% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of 2.23 USD, with revenue projected to reach 14.61 billion USD, implying an increase of 12.06% EPS, and increase of 11.41% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Novo-Nordisk A/S
Report Date
May 06, 2026 For Q1 26
Estimate
$5.38
Actual
$6.63
Surprise
+23.06%
logo
Pfizer Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
$0.72
Actual
$0.75
Surprise
+3.55%
logo
Innoviva, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
$0.39
Actual
-$0.05
Surprise
-112.57%
FAQ
For Q1 2026, Novartis AG reported EPS of $1.99, missing estimates by -8.52%, and revenue of $13.11B, -5.8% below expectations.
The stock price moved up 0.91%, changed from $144.19 before the earnings release to $145.50 the day after.
The next earning report is scheduled for Jul 21, 2026.
Based on 4 analysts, Novartis AG is expected to report EPS of $2.23 and revenue of $14.61B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement